Outcomes4Me Raises $21M to Transform Cancer Care with AI-Driven, NCCN-Integrated Guidance

Outcomes4Me is thrilled to announce that we have successfully raised $21,000,000 in a recent funding round, reinforcing our commitment to revolutionizing cancer care through advanced technology. This significant investment will accelerate our mission of leveraging artificial intelligence and machine learning to empower cancer patients as they navigate complex treatment landscapes. Our free digital platform offers doctor-approved and FDA-approved guidance tailored to each patient’s unique diagnosis, and now, with this new funding, we are poised to expand its capabilities even further. By integrating the prestigious NCCN Clinical Practice Guidelines in Oncology from a not-for-profit alliance of 33 leading cancer centers, Outcomes4Me stands at the forefront of delivering reliable, personalized treatment information alongside access to relevant clinical trials and genetic testing initiatives. The funds will be deployed to scale our operations, enhance our platform’s precision, and broaden our research and development efforts, ultimately ensuring that more patients receive timely and accurate treatment insights. Our journey has been marked by numerous recognitions—including the 2024 Fast Company World Changing Idea, MedTech Breakthrough Award, Inc. Regionals Northeast, Anthem Award, BuiltIn Best Place to Work, and the MassTLC Tech Top 50: CEO of the Year Award—which underscore our innovative impact and the trust placed in us by the industry. This milestone not only validates our approach but also fuels our ambition to continue pushing the boundaries of digital healthcare, making high-quality, personally tailored oncology insights accessible to every patient in need.